Current role
Justin J. File
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Justin J. File
Justin J. File is recorded as Board Member, CEO and CFO at Lite Strategy, Inc. (LITS). Lite Strategy, Inc. reported in an 8-K filed February 12, 2026 that Justin J. File was appointed Director, effective February 12, 2026. Lite Strategy, Inc. reported in an 8-K filed December 30, 2025 that Justin J. File was appointed Chief Executive Officer, effective November 14, 2025. Lite Strategy, Inc. reported in an 8-K filed November 18, 2025 that Justin J. File was appointed member of the Board, effective November 14, 2025. Equibles holds 9 filed executive changes naming Justin J. File; each is listed under recent activity with its source filing. The proxy statement of Lite Strategy, Inc. reports total compensation of $912,667 for Justin J. File in fiscal 2025, including a base salary of $541,667. Disclosed compensation is on record for 8 fiscal years.
“The following individuals, who were named as nominees in the Company’s definitive proxy statement relating to the Annual Meeting, were elected by the Company’s stockholders by a plurality of votes cast to serve until the expiration of their terms in fiscal year 2029 and until their successor is elected and qualified.”
“the Board of Directors (the Board) of the Company appointed Justin J. File as Chief Executive Officer, effective as of November 14, 2025, in addition to his current roles of Chief Financial Officer and Secretary.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-08-01–present
-
Evofem Biosciences, Inc. (EVFM)
SEC 8-K
Current2022-12-16–present
-
Current
Start not stated–present
-
Current
Start not stated–present
-
Start not stated–2023-04-03
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Evofem Biosciences, Inc.
Other people whose current roles at this company are on record from its filings.
- Saundra Pelletier CEO, Board Member
- Thomas Lynch Chairman
- Albert Altro CFO
- Ivy Zhang CFO
- Colin Rutherford Board Member
- Jenny Yip Board Member
- Kim Kamdar Board Member
- Lisa Rarick Board Member
- Lisa Rarick, M.D., F.A.C.O.G. Board Member
- Tony O’Brien Board Member
Leadership on record at Lite Strategy, Inc.
Other people whose current roles at this company are on record from its filings.
- David M. Urso CEO, Board Member
- Frederick W. Driscoll Chairman, Board Member
- Charles B. Lee Board Member
- Charlie Lee Board Member
- Cheryl Cohen Board Member
- James Flynn Board Member
- Joshua Riezman Board Member
- Kevan E. Clemens, Ph.D Board Member
- Nicholas R. Glover Board Member
- Norman C. Selby Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Lite Strategy, Inc. (LITS) | Acting Chief Executive Officer, Chief Financial Officer | $541,667 | $912,667 |
| 2024 | Lite Strategy, Inc. (LITS) | Chief Financial Officer | $450,000 | $614,700 |
| 2023 | Lite Strategy, Inc. (LITS) | Chief Financial Officer | $25,673 | $321,273 |
| 2022 | Evofem Biosciences, Inc. (EVFM) | Chief Financial Officer | $589,240 | $767,453 |
| 2021 | Evofem Biosciences, Inc. (EVFM) | Chief Financial Officer | $589,240 | $1,042,172 |
| 2020 | Evofem Biosciences, Inc. (EVFM) | Chief Financial Officer | $566,577 | $2,014,035 |
| 2019 | Evofem Biosciences, Inc. (EVFM) | Chief Financial Officer | $611,807 | $1,183,010 |
| 2018 | Evofem Biosciences, Inc. (EVFM) | Chief Financial Officer | $578,473 | $3,299,756 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.